The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Histopathologic Features of Mycobacterium ulcerans Infection
Open accessAbstract
Because of the emergence of Buruli ulcer disease, the World Health Organization launched a Global Buruli Ulcer Initiative in 1998. This indolent skin infection is caused by Mycobacterium ulcerans. During a study of risk factors for the disease in Ghana, adequate excisional skin-biopsy specimens were obtained from 124 clinically suspicious lesions. Buruli ulcer disease was diagnosed in 78 lesions since acid-fast bacilli (AFB) were found by histopathologic examination. Lesions with other diagnoses included filariasis (3 cases), zygomycosis (2 cases), ulcerative squamous cell carcinomas (2 cases), keratin cyst (1 case), and lymph node (1 case). Thirty-seven specimens that did not show AFB were considered suspected Buruli ulcer disease cases. Necrosis of subcutaneous tissues and dermal collagen were found more frequently in AFB-positive specimens compared with specimens from suspected case-patients (p<0.001). Defining histologic criteria for a diagnosis of Buruli ulcer disease is of clinical and public health importance since it would allow earlier treatment, leading to less deforming sequelae.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mycolactone: A Polyketide Toxin from Mycobacterium ulcerans Required for Virulence
George, K. M., Chatterjee, D., Gunawardana, G., Welty, D., Hayman, J., Lee, R., & Small, P. L. C. (1999) · Science · doi:10.1126/science.283.5403.854 · Cited by 641
Research works printed but not linked: 18
- Uganda Buruli Group, 1970, Clinical features and treatment of pre-ulcerative Buruli lesions (Mycobacterium ulcerans infection), report II of the Uganda Buruli group., BMJ, 2, 390, 10.1136/bmj.2.5706.390 · doi:10.1136/bmj.2.5706.390
- King CH, Ashford DA, Dobos KM, Spotts Whitney EA, Raghunathan PL, Guarner J,Mycobacterium ulceransinfection and Buruli ulcer disease: emergence of a public health dilemma. In: Scheld WM, Craig WA, Hughes JM, editors. Emerging infections. Washington (DC): American Society of Microbiology Press; 2001;9:137–52.
- van der Werf, 1999, Mycobacterium ulcerans infection., Lancet, 354, 1013, 10.1016/S0140-6736(99)01156-3 · DOI · Paper page
- Guimaraes-Peres, 1999, Comparison of two PCRs for detection of Mycobacterium ulcerans., J Clin Microbiol, 37, 206, 10.1128/JCM.37.1.206-208.1999 · doi:10.1128/jcm.37.1.206-208.1999
- Portaels, 1997, Direct detection and identification of Mycobacterium ulcerans in clinical specimens by PCR and oligonucleotide-specific capture plate hybridization., J Clin Microbiol, 35, 1097, 10.1128/JCM.35.5.1097-1100.1997 · DOI
- Connor, 1966, Buruli ulceration, a clinicopathologic study of 38 Ugandans with Mycobacterium ulcerans ulceration., Arch Pathol, 81, 183
- Hayman, 1993, Out of Africa: observations on the histopathology of Mycobacterium ulcerans infection., J Clin Pathol, 46, 5, 10.1136/jcp.46.1.5 · DOI
- Amofah, 2002, Buruli ulcer in Ghana: results of a national case search., Emerg Infect Dis, 8, 167, 10.3201/eid0802.010119 · DOI · Paper page
- Stienstra, 2003, Analysis of an IS2402-based nested PCR for diagnosis of Buruli ulcer disease in regions of Ghana where the disease is endemic., J Clin Microbiol, 41, 794, 10.1128/JCM.41.2.794-797.2003 · doi:10.1128/jcm.41.2.794-797.2003
- Clancey, 1961, Mycobacterial skin ulcers in Uganda., Lancet, 2, 951, 10.1016/S0140-6736(61)90793-0 · DOI
- Krieg, 1974, Toxin of Mycobacterium ulcerans, production and effects in guinea pig skin., Arch Dermatol, 110, 783, 10.1001/archderm.1974.01630110073023 · doi:10.1001/archderm.1974.01630110073023
- George, 1998, Partial purification and characterization of biological effects of a lipid toxin produced by Mycobacterium ulcerans., Infect Immun, 66, 587, 10.1128/IAI.66.2.587-593.1998 · DOI
- Dobos, 2001, Mycobacterium ulcerans cytotoxicity in an adipose cell model., Infect Immun, 69, 7182, 10.1128/IAI.69.11.7182-7186.2001 · DOI
- Dodge, 1964, Mycobacterial skin ulcers in Uganda: histopathological and experimental aspects., J Pathol Bacteriol, 88, 167, 10.1002/path.1700880122 · doi:10.1002/path.1700880122
- Hayman, 1996, Pseudoepitheliomatous hyperplasia in Mycobacterium ulcerans infection., Pathology, 28, 131, 10.1080/00313029600169733 · doi:10.1080/00313029600169733
- Hayman, 1985, The pathology of Micobacterium ulcerans infection., Pathology, 17, 594, 10.3109/00313028509084759 · DOI
- Meyers, 1974, Human Mycobacterium ulcerans infections developing at sites of trauma to skin., Am J Trop Med Hyg, 23, 919, 10.4269/ajtmh.1974.23.919 · doi:10.4269/ajtmh.1974.23.919
- Evans, 1999, Squamous cell carcinoma secondary to Buruli ulcer., Trans R Soc Trop Med Hyg, 93, 63, 10.1016/S0035-9203(99)90181-5 · doi:10.1016/s0035-9203(99)90181-5
Cited by
Extrapulmonary Infections Associated with Nontuberculous Mycobacteria in Immunocompetent Persons
Piersimoni, C., & Scarparo, C. (2009) · Emerging Infectious Diseases · doi:10.3201/eid1509.070616 · Cited by 263
Buruli ulcer: reductive evolution enhances pathogenicity of Mycobacterium ulcerans
Demangel, C., Stinear, T. P., & Cole, S. T. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2077 · Cited by 197
Shen, Y., Ye, B., Chen, P., Wang, Q., Fan, C., Shu, Y., & Xiang, M. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00394 · Cited by 105
Torrado, E., Adusumilli, S., Fraga, A. G., Small, P. L. C., Castro, A. G., & Pedrosa, J. (2007) · Infection and Immunity · doi:10.1128/iai.00290-07 · Cited by 95
Lee, H.-M., Shin, D.-M., Choi, D.-K., Lee, Z.-W., Kim, K.-H., Yuk, J.-M., Kim, C. D., Lee, J.-H., & Jo, E.-K. (2009) · Cellular Microbiology · doi:10.1111/j.1462-5822.2009.01285.x · Cited by 69
Hall, B., & Simmonds, R. (2014) · Biochemical Society Transactions · doi:10.1042/bst20130133 · Cited by 52
Metadata
- Authors
- Guarner, J., Bartlett, J., Whitney, E. A. S., Raghunathan, P. L., Stienstra, Y., Asamoa, K., Etuaful, S., Klutse, E., Quarshie, E., van der Werf, T. S., van der Graaf, W. T. A., King, C. H., & Ashford, D. A.
- Venue
- Emerging Infectious Diseases
- Published
- 2003-06
- Volume
- 9
- Issue
- 6
- Pages
- 651-656
- ISSN
- 1080-6040 (ISSN-L)
- 1080-6059
- OpenAlex
- W2147031727
- Cited by
- 164
- References
- 1
- FWCI
- 5.83
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.